-
公开(公告)号：US10556963B2
公开(公告)日：2020-02-11
申请号：US15105076
申请日：2014-12-17
Applicant: AIMM Therapeutics B.V.
Inventor： Hergen Spits , Tim Beaumont , Marijn Aletta Gillissen , Adrianus Quirinus Bakker , Mette Deborah Hazenberg , Martijn Kedde
Abstract: The invention provides human AML-specific binding compounds that are able to bind a cell surface component of AML cells. Therapeutic uses of binding compounds against AML are also provided.
-
2.发明申请MEANS AND METHODS FOR COUNTERACTING MYELOPROLIFERATIVE OR LYMPHOPROLIFERATIVE DISORDERS 审中-公开逆转髓磷脂或淋巴细胞增多症的手段和方法公开(公告)号：US20160326261A1
公开(公告)日：2016-11-10
申请号：US15105076
申请日：2014-12-17
Applicant: AIMM THERAPEUTICS B.V.
Inventor： Hergen SPITS , Tim BEAUMONT , Marijn Aletta GILLISSEN , Adrianus Quirinus BAKKER , Mette Deborah Hazenberg
IPC: C07K16/30 , G01N33/574 , C12P21/00 , A61K47/48 , C07K16/40
Abstract: The invention provides human AML-specific binding compounds that are able to bind a cell surface component of AML cells. Therapeutic uses of binding compounds against AML are also provided.
Abstract translation: 本发明提供能够结合AML细胞的细胞表面组分的人类AML特异性结合化合物。 还提供了针对AML的结合化合物的治疗用途。
-
Search Results
2
records
(took 0.019 seconds)
